Picture EBD Group Connector Personal Networking in Life Sciences 650x80
Employment/Membership › Details

BMS–Mily E: management, 202003– EVP Strategy + Business Development before Barclays + Thermo Fisher + Goldman Sachs


Period Period 2020-03-31
Organisations Organisation Bristol-Myers Squibb Co. (BMS) (NYSE: BMY)
  Group Bristol-Myers Squibb (BMS) (Group)
  Organisation 2 Barclays (Group)
Products Product pharmaceutical
  Product 2 investment banking
Person Person Mily, Elizabeth (BMS 202003– EVP Strategy + Business Development before Barclays + Thermo Fisher + Goldman Sachs)

Bristol-Myers Squibb Company. (3/18/20). "Press Release: Bristol Myers Squibb Appoints Elizabeth Mily as Executive Vice President, Strategy & Business Development". New York, NY.

Bristol Myers Squibb Company (NYSE:BMY) announced today that Elizabeth Mily has been appointed Executive Vice President, Strategy & Business Development, effective March 30, 2020. In this role, Mily will oversee company strategy and all business development activities, including strategic partnerships, mergers and acquisitions, as well as other strategic initiatives.

“Elizabeth is an accomplished leader in investment banking and health care M&A, and I look forward to the important role she will play in sourcing external innovation to drive our vision of transforming patients’ lives through science,” said Giovanni Caforio, chairman and chief executive officer, Bristol Myers Squibb. “I am excited to welcome her to Bristol Myers Squibb as we position the company for continued growth through high performing brands, upcoming new product launches, an exciting pipeline, and the financial strength to pursue innovation for the next wave of new medicines.”

Mily will report to Caforio and will be a member of the Bristol Myers Squibb leadership team.

Mily joins Bristol Myers Squibb from Barclays, where she was the Managing Director and Chair of the Global Lifesciences group in the global healthcare unit. During her career she has executed over $200 billion in completed M&A advisory assignments and has advised on an extensive amount of debt, equity and equity-linked financings. Prior to joining Barclays, Mily served as Head of Corporate Strategy and Development at Thermo Fisher Scientific. Prior to that she spent 16 years at Goldman, Sachs & Co. where she was a Managing Director and senior coverage officer within the Healthcare Department of the Investment Banking Division.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.



Tim Power, 609-252-7509,
Nina Goworek, 908-673-9711,

Record changed: 2020-11-20


Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

More documents for Bristol-Myers Squibb (BMS) (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top